News

Eli Lilly weight loss pill shows promise in latest clinical trial, company says
In a Phase 3 trial, drugmaker Eli Lilly and Company said it's oral GLP-1 pill showed similar results to injectable weight ...
Eli Lilly happy with weight loss pill performance as drugmaker races to be the first to market
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...
Eli Lilly's obesity pill led to around 12% weight loss in closely watched late-stage trial; shares drop
Eli Lilly said the highest dose of its daily obesity pill helped patients lose almost 12% of their body weight, or roughly 27 ...
Experimental GLP-1 pill helped people with obesity lose weight, Eli Lilly says
In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...
Eli Lilly closer to breakthrough weight loss drug; shares tumble as some question results
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body fat.
Eli Lilly Q2 Earnings: Ignore Oral Weight Loss Bombshell, This Is A Buy The Dip Moment
Eli Lilly stock dips despite strong Q2 results. Read my insights on obesity drug market dominance and why this selloff in LLY ...
Lilly’s Push to $1 Trillion Derailed by Trade Risks and Obesity Drug Speedbumps
A year ago, Eli Lilly & Co. was poised to become the first pharmaceutical company to register a trillion-dollar market ...
Wegovy maker Novo Nordisk warns on continued copycat-drug challenge as new CEO readied
Novo Nordisk cautioned on Wednesday that it expects continued competition this year from copycat versions of its Wegovy ...